Compound Global Advisors’s UnitedHealth UNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-162
Closed -$53.5K 35
2025
Q4
$53.5K Hold
162
2.97% 14
2025
Q3
$55.9K Hold
162
3.04% 12
2025
Q2
$50.5K Sell
162
-450
-74% -$172K 4.61% 12
2025
Q1
$288K Sell
612
-1,650
-73% -$843K 1.7% 24
2024
Q4
$1.14M Buy
+2,262
New +$1.29M 4.66% 5
2024
Q1
$10.1M Sell
20,354
-3,678
-15% -$1.87M 1.5% 22
2023
Q4
$12.7M Sell
24,032
-14,727
-38% -$7.85M 2.34% 22
2023
Q3
$19.5M Sell
38,759
-17,665
-31% -$8.69M 4.28% 8
2023
Q2
$27.1M Buy
56,424
+22,031
+64% +$10.8M 6.26% 1
2023
Q1
$16.3M Buy
+34,393
New +$16.6M 4.13% 10

Other funds holding UNH

Compound Global Advisors's UNH Position: Q1 2026 in Review

Compound Global Advisors sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 162 shares — an estimated $53.5K sold.

Compound Global Advisors first reported a position in UNH in Q1 2023 and held it in 10 quarters. The position peaked at $27.1M in Q2 2023. 3,019 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

  • Compound Global Advisors reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
  • Compound Global Advisors sold 162 UnitedHealth shares in Q1 2026, an estimated $53.5K.
  • Compound Global Advisors first reported a position in UnitedHealth in Q1 2023 and held it in 10 quarters.
  • Compound Global Advisors's UnitedHealth position peaked at $27.1M in Q2 2023.
  • 3,019 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Compound Global Advisors's 13F filing for Q1 2026, filed 7 May 2026.